Ignite Creation Date:
2025-12-25 @ 2:17 AM
Ignite Modification Date:
2026-01-22 @ 12:08 PM
Study NCT ID:
NCT06588660
Status:
TERMINATED
Last Update Posted:
2025-07-29
First Post:
2024-09-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
ST-067 and Teclistamab for the Treatment of Relapsed or Refractory Multiple Myeloma
Sponsor:
University of Washington
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-12-18
Start Date Type:
ACTUAL
Primary Completion Date:
2025-02-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-02-14
Completion Date Type:
ACTUAL
First Submit Date:
2024-09-06
First Submit QC Date:
None
Study First Post Date:
2024-09-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-24
Last Update Post Date:
2025-07-29
Last Update Post Date Type:
ACTUAL